< Back to catalogue
Rivaroxaban
August 3, 2026Sitagliptin
August 3, 2026PHARMAZAC
Sitagliptin + Metformin
Sitagliptin/Metformin | Hypoglycemic | Business Development
| F.C. TABS (50+850)MG |
| F.C. TABS (50+1000)MG |
| F.C. TABS (50+850)MG |
| F.C. TABS (50+1000)MG |
| ACTIVE SUBSTANCE | |
|---|---|
| MARKETING AUTHORISATION HOLDER | |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| STATUS | Available |
| THERAPEUTIC AREA |
